New cell therapy takes on Drug-Resistant melanoma
NCT ID NCT06708455
First seen Apr 04, 2026 · Last updated May 02, 2026 · Updated 2 times
Summary
This phase 2 trial tests a new cell therapy called RAPA-201 for people with advanced melanoma that has spread or come back after standard immunotherapy. The treatment uses a patient's own immune cells that are specially trained to resist a drug called rapamycin, aiming to boost their cancer-fighting power. About 65 adults with stage IIIc or IV melanoma that no longer responds to PD-(L)1 inhibitors will receive this therapy to see if it can shrink tumors and improve survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Hackensack University Medical Center
Hackensack, New Jersey, 07601, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.